Publications by authors named "Swati Tole"

Claim this Profile
E
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study.
Silvio Danese, Jean-Frederic Colombel, Milan Lukas, Javier P Gisbert, Geert D'Haens, Swati Tole

Lancet Gastroenterol Hepatol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial.
Laurent Peyrin-Biroulet, Ailsa Hart, Peter Bossuyt, Millie Long, Matthieu Allez, Swati Tole

Lancet Gastroenterol Hepatol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials.
David T Rubin, Iris Dotan, Aaron DuVall, Yoram Bouhnik, Graham Radford-Smith, Swati Tole

Lancet Gastroenterol Hepatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Severine Vermeire, Peter L Lakatos, Timothy Ritter, Stephen Hanauer, Brian Bressler, Swati Tole

Lancet Gastroenterol Hepatol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory Bowel Disease Patients' Perspectives of Clinical Trials: A Global Quantitative and Qualitative Analysis.
David T Rubin, Laurent Peyrin-Biroulet, Walter Reinisch, Swati Tole, Laura Sullivan

Crohns Colitis 360· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of lymphocyte homing and retention through α4β7 and αEβ7 inhibition in inflammatory bowel disease.
Bingbing Dai, Jason A Hackney, Ryan Ichikawa, Allen Nguyen, Justin Elstrott, Swati Tole

Cell Rep Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open-Label Tolerability and Actual-Use Human Factors Study of Etrolizumab Autoinjector in Healthy Volunteers.
Helen Tyrrell, Renato Ravanello, Jennifer Pulley, Meina Tao Tang, Wenhui Zhang, Swati Tole

Adv Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etrolizumab for the Treatment of Ulcerative Colitis and Crohn's Disease: An Overview of the Phase 3 Clinical Program.
William J Sandborn, Severine Vermeire, Helen Tyrrell, Azra Hassanali, Stuart Lacey, Swati Tole

Adv Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies.
Iris Dotan, Matthieu Allez, Silvio Danese, Mary Keir, Swati Tole

Med Res Rev· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Listening to the Patient: Improving the Design and Conduct of Clinical Trials in Inflammatory Bowel Diseases.
Dan Sharp, Sara Ringer, K T Park, Swati Tole, David T Rubin

Crohns Colitis 360· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of rituximab in combination with other biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: an open-label study.
William F C Rigby, Philip J Mease, Ewa Olech, Mark Ashby, Swati Tole

J Rheumatol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and cost-effectiveness of strategies to expand antiretroviral therapy in St. Petersburg, Russia.
Elisa F Long, Margaret L Brandeau, Cristina M Galvin, Tatyana Vinichenko, Swati P Tole

AIDS· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis